Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Advanced Search
Wizards and Analytics Search
Simple Search
By Subject Area
Sales and Marketing > New Product Development and Launch > Ensuring Market Focus > Customer and Thought Leader Involvement
Customer and Thought Leader Involvement Research

Oncology Market Education: Engaging Key Opinion Leaders 
Non-members: Click here to review a complimentary excerpt from "Oncology Market Education: Engaging Key Opinion Leaders" STUDY OVERVIEW Educating the marketplace about a new product is part of every new product launch... (ID 5168)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2400.00   Free Excerpt Available
Oncology Market Education: Timing and Lessons Learned 
Non-members: Click here to review a complimentary excerpt from "Oncology Market Education: Timing and Lessons Learned" STUDY OVERVIEW Informing critical stakeholders about new therapies is an important part of any new product launch - and new oncology products are no different... (ID 5167)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $1500.00   Free Excerpt Available
Oncology Market Education: Informing Patients and Payers 
Non-members: Click here to review a complimentary excerpt from "Oncology Market Education: Informing Patients and Payers" STUDY OVERVIEW Patient and payer support plays an important part in the success of a new oncology product entering the market... (ID 5166)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2400.00   Free Excerpt Available
Oncology Market Education: Communicating with the Medical Community 
Non-members: Click here to review a complimentary excerpt from "Oncology Market Education: Communicating with the Medical Community" STUDY OVERVIEW The success of an oncology product launch hinges on many things but one of the critical components is the reception in the medical community... (ID 5165)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $1800.00   Free Excerpt Available
Payer Factors that Shape a Successful Oncology Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Oncology Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how an oncology product fares in the marketplace... (ID 5156)
Companies Profiled: GlaxoSmithKline , Bristol-Myers Squibb, Roche, Lilly, more ...
Price: $1764.00   Free Excerpt Available
Physician Factors that Shape a Successful Oncology Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Oncology Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly developing and launching new oncology products... (ID 5151)
Companies Profiled: GlaxoSmithKline , Bristol-Myers Squibb, Roche, Lilly, more ...
Price: $2548.00   Free Excerpt Available
Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly developing and launching new metabolic products... (ID 5137)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2397.00   Free Excerpt Available
Physician Factors that Shape a Successful Cardiovascular Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Cardiovascular Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly developing and launching new cardiovascular products... (ID 5128)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2325.00   Free Excerpt Available
Physician Factors that Shape a Successful Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly launching new products across multiple therapeutic areas... (ID 5117)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2325.00   Free Excerpt Available
Maintaining an Effective Managed Care Pull-Through Organization: Engaging External Stakeholders & Performance Measurement 
Non-members: Click here to review a complimentary excerpt from "Maintaining an Effective Managed Care Pull-Through Organization: Engaging External Stakeholders & Performance Measurement" STUDY OVERVIEW A pharmaceutical product can't find success in the marketplace without formulary access... (ID 5085)
Companies Profiled: Abbott, Bayer Healthcare, Johnson & Johnson, GlaxoSmithKline , more ...
Price: $2864.00   Free Excerpt Available
Supporting Successful Product Launches: Tactics for Educating Physicians 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Product Launches: Tactics for Educating Physicians" Study Overview Educating the marketplace about a new product is a vital prerequisite for both a therapy's launch and the critical first years on the market... (ID 5078)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2385.00   Free Excerpt Available
Supporting Successful Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Product Launches: Tactics for Educating Thought Leaders" Study Overview Educating the marketplace about a new product is an essential component of a successful launch and market positioning... (ID 5077)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2610.00   Free Excerpt Available
Supporting Successful Diabetes Product Launches: Tactics for Educating Physicians 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Diabetes Product Launches: Tactics for Educating Physicians" Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents... (ID 5072)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2475.00   Free Excerpt Available
Supporting Successful Diabetes Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Diabetes Product Launches: Tactics for Educating Thought Leaders" Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents... (ID 5071)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2745.00   Free Excerpt Available
Supporting Successful Oncology Product Launches: Tactics for Educating Physicians 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Oncology Product Launches: Tactics for Educating Physicians" Note: Data in this study are segmented to present views for Total Benchmark Class and Oncology respondents... (ID 5065)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2568.00   Free Excerpt Available
Supporting Successful Oncology Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Oncology Product Launches: Tactics for Educating Thought Leaders" Note: Data in this study are segmented to present views for Total Benchmark Class and Oncology respondents... (ID 5064)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2279.00   Free Excerpt Available
Erbitux Case Study: Using Congresses to Educate the Oncology Community 
Non-members: Click here to review a complimentary excerpt from "Erbitux Case Study: Using Congresses to Educate the Oncology Community" STUDY OVERVIEW Cetuximab – marketed as “Erbitux” – won its initial US approval in 2004 and by 2006 became a blockbuster oncology product... (ID 5060)
Companies Profiled: Bristol-Myers Squibb, Eli Lilly and Company, Merck Serono, ImClone Systems Inc.
Price: $1500.00   Free Excerpt Available
Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging and Supporting Patients 
Non-members: Click here to review a complimentary excerpt from "Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging, and Supporting Patients" STUDY OVERVIEW With so much riding on the consumers’ acceptance of a product, it is only logical when designing marketing strategies to have in place initiatives that focus on the unfulfilled needs of the population... (ID 5058)
Companies Profiled: Acorda Therapeutics, Sanofi-aventis, Amgen, Bayer, more ...
Price: $4575.00   Free Excerpt Available
Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and Patients 
Non-members: Click here to review a complimentary excerpt from "Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and Patients" STUDY OVERVIEW As the first oral cancer therapy that inhibits both tumor and tumor blood vessel growth, Nexavar has proven to be an important weapon against advanced kidney and liver cancers... (ID 5057)
Companies Profiled: Bayer, Onyx Pharmaceuticals
Price: $1900.00   Free Excerpt Available
Marketing Activities for Pharmaceutical Launches 
NonMembers: Click here to download a complimentary excerpt of this research... (ID 4572)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline , more ...
Price: $1988.95
Patient Advocacy & Professional Relations Research Bundle 
A comprehensive introduction to the value that strong relationships with patient advocacy groups bring to pharmaceutical companies... (ID 4552)
Companies Profiled: A Leading Pharmaceutical Company, Sanofi-aventis, Abbott Laboratories, AstraZeneca, more ...
Price: $1992.00

 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.